PDB-code
Browse kinase entries (page 133 of 282)
First 129 130 131 PreviousLast137 136 135 Next| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File |
|---|---|---|---|---|---|---|---|---|---|---|
 | GSK3B | GSK | CMGC | 6hk4 | B | A | 3-azanyl-6-(4-morpholin-4-ylsulfonylphenyl)-~{n}-pyridin-3-yl-pyrazine-2-carboxamide | Human | Show |  |
| GSK3B | GSK | CMGC | 6hk4 | B | B | 3-azanyl-6-(4-morpholin-4-ylsulfonylphenyl)-~{n}-pyridin-3-yl-pyrazine-2-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6hk7 | A | 3-azanyl-~{n}-(2-methoxyethyl)-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 6tcu | A | A | 5-[2,3-bis(fluoranyl)phenyl]-~{n}-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-1~{h}-indazole-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6tcu | A | B | 5-[2,3-bis(fluoranyl)phenyl]-~{n}-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-1~{h}-indazole-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6v6l | A | A | - | Human | Show | |
| GSK3B | GSK | CMGC | 6v6l | A | B | - | Human | Show | |
| GSK3B | GSK | CMGC | 6y9r | A | A | ~{n}-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-5-(5-propan-2-yloxypyridin-3-yl)-1~{h}-indazole-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6y9r | A | B | ~{n}-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-5-(5-propan-2-yloxypyridin-3-yl)-1~{h}-indazole-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6y9s | A | A | ~{n}-(oxan-4-ylmethyl)-6-(5-propan-2-yloxypyridin-3-yl)imidazo[1,5-a]pyridine-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6y9s | A | B | ~{n}-(oxan-4-ylmethyl)-6-(5-propan-2-yloxypyridin-3-yl)imidazo[1,5-a]pyridine-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6y9s | B | A | ~{n}-(oxan-4-ylmethyl)-6-(5-propan-2-yloxypyridin-3-yl)imidazo[1,5-a]pyridine-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 6y9s | B | B | ~{n}-(oxan-4-ylmethyl)-6-(5-propan-2-yloxypyridin-3-yl)imidazo[1,5-a]pyridine-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 7b6f | A | A | 3-[(3~{s})-3-[(7-chloranyl-9~{h}-pyrimido[4,5-b]indol-4-yl)-methyl-amino]piperidin-1-yl]propanenitrile | Human | Show | |
| GSK3B | GSK | CMGC | 7b6f | A | B | 3-[(3~{s})-3-[(7-chloranyl-9~{h}-pyrimido[4,5-b]indol-4-yl)-methyl-amino]piperidin-1-yl]propanenitrile | Human | Show | |
| GSK3B | GSK | CMGC | 7oy5 | A | A | ~{n}4-(3-cyclopropyl-1~{h}-pyrazol-5-yl)-~{n}2-(phenylmethyl)thieno[3,2-d]pyrimidine-2,4-diamine | Human | Show | |
| GSK3B | GSK | CMGC | 7oy5 | A | B | ~{n}4-(3-cyclopropyl-1~{h}-pyrazol-5-yl)-~{n}2-(phenylmethyl)thieno[3,2-d]pyrimidine-2,4-diamine | Human | Show | |
| GSK3B | GSK | CMGC | 7sxh | A | A | (4s,5r,8r)-4-ethyl-8-fluoro-4-[3-(3-fluoro-5-methoxypyridin-4-yl)phenyl]-7,7-dimethyl-4,5,6,7,8,9-hexahydro-2h-pyrazolo[3,4-b]quinolin-5-ol | Human | Show | |
| GSK3B | GSK | CMGC | 7sxh | A | B | (4s,5r,8r)-4-ethyl-8-fluoro-4-[3-(3-fluoro-5-methoxypyridin-4-yl)phenyl]-7,7-dimethyl-4,5,6,7,8,9-hexahydro-2h-pyrazolo[3,4-b]quinolin-5-ol | Human | Show | |
| GSK3B | GSK | CMGC | 7sxj | A | A | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 7sxj | A | B | (4~{s})-4-ethyl-7,7-dimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | Human | Show | |
| GSK3B | GSK | CMGC | 7u2z | A | A | (3r)-1-[3-(2-fluorophenyl)propanoyl]-n-(pyridin-2-yl)pyrrolidine-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 7u2z | A | B | (3r)-1-[3-(2-fluorophenyl)propanoyl]-n-(pyridin-2-yl)pyrrolidine-3-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 7u31 | A | A | 5-(4-fluorophenyl)-4-[1-(methanesulfonyl)azetidin-3-yl]pyrimidin-2-amine | Human | Show | |
| GSK3B | GSK | CMGC | 7u31 | A | B | 5-(4-fluorophenyl)-4-[1-(methanesulfonyl)azetidin-3-yl]pyrimidin-2-amine | Human | Show | |
| GSK3B | GSK | CMGC | 7u33 | A | A | 3-[2-amino-5-(4-fluorophenyl)pyrimidin-4-yl]-n,n-dimethylazetidine-1-sulfonamide | Human | Show | |
| GSK3B | GSK | CMGC | 7u33 | A | B | 3-[2-amino-5-(4-fluorophenyl)pyrimidin-4-yl]-n,n-dimethylazetidine-1-sulfonamide | Human | Show | |
| GSK3B | GSK | CMGC | 7u36 | A | (3s)-1-[(2-fluorophenoxy)acetyl]-n-(pyridin-2-yl)pyrrolidine-3-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 7z1f | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | Show | | |
| GSK3B | GSK | CMGC | 7z1g | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | Show | | |
| GSK3B | GSK | CMGC | 8auz | A | A | 8-morpholin-4-yl-2-pyridin-3-yl-[1,3]oxazolo[5,4-f]quinoxaline | Human | Show | |
| GSK3B | GSK | CMGC | 8auz | A | B | 8-morpholin-4-yl-2-pyridin-3-yl-[1,3]oxazolo[5,4-f]quinoxaline | Human | Show | |
| GSK3B | GSK | CMGC | 8av1 | A | A | 2-pyridin-3-yl-8-thiomorpholin-4-yl-[1,3]oxazolo[5,4-f]quinoxaline | Human | Show | |
| GSK3B | GSK | CMGC | 8av1 | A | B | 2-pyridin-3-yl-8-thiomorpholin-4-yl-[1,3]oxazolo[5,4-f]quinoxaline | Human | Show | |
| GSK3B | GSK | CMGC | 8djc | A | A | (4s)-n-{4-[(2s)-2-methylmorpholin-4-yl]pyridin-3-yl}-2-phenylimidazo[1,2-b]pyridazine-8-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 8djc | A | B | (4s)-n-{4-[(2s)-2-methylmorpholin-4-yl]pyridin-3-yl}-2-phenylimidazo[1,2-b]pyridazine-8-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 8djd | A | A | 2-[(cyclopropanecarbonyl)amino]-n-(5-phenylpyridin-3-yl)pyridine-4-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 8djd | A | B | 2-[(cyclopropanecarbonyl)amino]-n-(5-phenylpyridin-3-yl)pyridine-4-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 8dje | A | A | (4s)-3-[(cyclopropylmethyl)amino]-n-(4-phenylpyridin-3-yl)imidazo[1,2-b]pyridazine-8-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 8dje | A | B | (4s)-3-[(cyclopropylmethyl)amino]-n-(4-phenylpyridin-3-yl)imidazo[1,2-b]pyridazine-8-carboxamide | Human | Show | |
| GSK3B | GSK | CMGC | 8ff8 | A | 2-(4-cyanoanilino)-n-(4-phenylpyridin-3-yl)pyrimidine-4-carboxamide | Human | Show | | |
| GSK3B | GSK | CMGC | 8qji | A | n-[4-[5-(1,2,4-oxadiazol-3-yl)thiophen-2-yl]pyridin-2-yl]cyclopropanecarboxamide | Human | Show | | |
| GUCY2C (HSER) | RGC | RGC | 8fx4 | D | - | Human | Show | | |
| HASPIN (Haspin) | Haspin | Other | 2vuw | A | A | (2r,3r,4s,5r)-2-(4-amino-5-iodo-7h-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | Human | Show | |
| HASPIN (Haspin) | Haspin | Other | 2vuw | A | B | (2r,3r,4s,5r)-2-(4-amino-5-iodo-7h-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | Human | Show | |
| HASPIN (Haspin) | Haspin | Other | 2wb8 | A | A | - | Human | Show | |
| HASPIN (Haspin) | Haspin | Other | 2wb8 | A | B | - | Human | Show | |
| HASPIN (Haspin) | Haspin | Other | 3dlz | A | A | adenosine monophosphate | Human | Show | |
| HASPIN (Haspin) | Haspin | Other | 3dlz | A | B | adenosine monophosphate | Human | Show | |
| HASPIN (Haspin) | Haspin | Other | 3e7v | A | A | 3-(3-aminophenyl)-n-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine | Human | Show | |
